vs
Abacus Global Management, Inc.（ABX）与RIGEL PHARMACEUTICALS INC（RIGL）财务数据对比。点击上方公司名可切换其他公司
Abacus Global Management, Inc.的季度营收约是RIGEL PHARMACEUTICALS INC的1.0倍（$71.9M vs $69.8M），RIGEL PHARMACEUTICALS INC净利率更高（384.0% vs 10.1%，领先374.0%），Abacus Global Management, Inc.同比增速更快（116.5% vs 21.2%），过去两年Abacus Global Management, Inc.的营收复合增速更高（82.9% vs 53.7%）
Abacus集团是澳大利亚ASX 200指数成分公众上市公司，专注投资澳大利亚房地产投资信托，投资组合集中在写字楼与自助仓储领域，同时管理房地产开发的legacy投资项目。该公司原名为Abacus地产集团，2023年8月拆分出了自助仓储业务Abacus Storage King。
Rigel制药是一家临床阶段生物技术企业，专注于研发及商业化针对自身免疫性疾病、炎症性疾病与血液疾病的靶向小分子疗法，核心市场位于美国，旗下已获批产品可治疗成人免疫性血小板减少症，致力于满足未被覆盖的临床医疗需求。
ABX vs RIGL — 直观对比
营收规模更大
ABX
是对方的1.0倍
$69.8M
营收增速更快
ABX
高出95.3%
21.2%
净利率更高
RIGL
高出374.0%
10.1%
两年增速更快
ABX
近两年复合增速
53.7%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $71.9M | $69.8M |
| 净利润 | $7.2M | $268.1M |
| 毛利率 | 88.8% | 91.5% |
| 营业利润率 | 31.7% | 33.2% |
| 净利率 | 10.1% | 384.0% |
| 营收同比 | 116.5% | 21.2% |
| 净利润同比 | 139.6% | 1769.2% |
| 每股收益（稀释后） | $0.06 | $14.11 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ABXRIGL
| Q4 25 | $71.9M | $69.8M | ||
| Q3 25 | $63.0M | $69.5M | ||
| Q2 25 | $56.2M | $101.7M | ||
| Q1 25 | $44.1M | $53.3M | ||
| Q4 24 | $33.2M | $57.6M | ||
| Q3 24 | $28.1M | $55.3M | ||
| Q2 24 | $29.1M | $36.8M | ||
| Q1 24 | $21.5M | $29.5M |
净利润ABXRIGL
| Q4 25 | $7.2M | $268.1M | ||
| Q3 25 | $7.1M | $27.9M | ||
| Q2 25 | $17.6M | $59.6M | ||
| Q1 25 | $4.6M | $11.4M | ||
| Q4 24 | $-18.3M | $14.3M | ||
| Q3 24 | $-5.1M | $12.4M | ||
| Q2 24 | $770.0K | $-1.0M | ||
| Q1 24 | $-1.3M | $-8.2M |
毛利率ABXRIGL
| Q4 25 | 88.8% | 91.5% | ||
| Q3 25 | 87.8% | 93.2% | ||
| Q2 25 | 89.2% | 95.6% | ||
| Q1 25 | 83.9% | 91.7% | ||
| Q4 24 | 88.8% | 89.9% | ||
| Q3 24 | 92.2% | 85.5% | ||
| Q2 24 | 90.6% | 92.4% | ||
| Q1 24 | 87.3% | 93.1% |
营业利润率ABXRIGL
| Q4 25 | 31.7% | 33.2% | ||
| Q3 25 | 35.6% | 40.9% | ||
| Q2 25 | 40.1% | 60.1% | ||
| Q1 25 | 47.6% | 23.9% | ||
| Q4 24 | -50.5% | 28.9% | ||
| Q3 24 | 24.3% | 25.4% | ||
| Q2 24 | 23.3% | 1.2% | ||
| Q1 24 | 10.5% | -23.6% |
净利率ABXRIGL
| Q4 25 | 10.1% | 384.0% | ||
| Q3 25 | 11.2% | 40.2% | ||
| Q2 25 | 31.3% | 58.6% | ||
| Q1 25 | 10.5% | 21.5% | ||
| Q4 24 | -55.0% | 24.9% | ||
| Q3 24 | -18.2% | 22.5% | ||
| Q2 24 | 2.6% | -2.8% | ||
| Q1 24 | -6.3% | -27.9% |
每股收益（稀释后）ABXRIGL
| Q4 25 | $0.06 | $14.11 | ||
| Q3 25 | $0.07 | $1.46 | ||
| Q2 25 | $0.18 | $3.28 | ||
| Q1 25 | $0.05 | $0.63 | ||
| Q4 24 | $-0.26 | $0.82 | ||
| Q3 24 | $-0.07 | $0.70 | ||
| Q2 24 | $0.01 | $-0.06 | ||
| Q1 24 | $-0.02 | $-0.47 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $38.1M | $155.0M |
| 总债务越低越好 | $405.8M | $52.5M |
| 股东权益账面价值 | $418.5M | $391.5M |
| 总资产 | $902.2M | $513.6M |
| 负债/权益比越低杠杆越低 | 0.97× | 0.13× |
8季度趋势，按日历期对齐
现金及短期投资ABXRIGL
| Q4 25 | $38.1M | $155.0M | ||
| Q3 25 | $86.4M | $137.1M | ||
| Q2 25 | $74.8M | $108.4M | ||
| Q1 25 | $43.8M | $77.1M | ||
| Q4 24 | $131.9M | $77.3M | ||
| Q3 24 | $19.4M | $61.1M | ||
| Q2 24 | $91.3M | $49.1M | ||
| Q1 24 | $65.4M | $49.5M |
总债务ABXRIGL
| Q4 25 | $405.8M | $52.5M | ||
| Q3 25 | $409.3M | $60.0M | ||
| Q2 25 | — | $60.0M | ||
| Q1 25 | — | $60.0M | ||
| Q4 24 | $380.8M | $60.0M | ||
| Q3 24 | — | $60.0M | ||
| Q2 24 | — | $60.0M | ||
| Q1 24 | — | $60.0M |
股东权益ABXRIGL
| Q4 25 | $418.5M | $391.5M | ||
| Q3 25 | $434.6M | $117.6M | ||
| Q2 25 | $416.5M | $81.9M | ||
| Q1 25 | $430.6M | $18.6M | ||
| Q4 24 | $423.3M | $3.3M | ||
| Q3 24 | $257.9M | $-14.6M | ||
| Q2 24 | $256.8M | $-29.9M | ||
| Q1 24 | $165.3M | $-31.7M |
总资产ABXRIGL
| Q4 25 | $902.2M | $513.6M | ||
| Q3 25 | $918.9M | $242.5M | ||
| Q2 25 | $848.4M | $206.7M | ||
| Q1 25 | $856.5M | $176.0M | ||
| Q4 24 | $874.2M | $164.0M | ||
| Q3 24 | $477.3M | $139.4M | ||
| Q2 24 | $483.9M | $128.4M | ||
| Q1 24 | $376.7M | $126.5M |
负债/权益比ABXRIGL
| Q4 25 | 0.97× | 0.13× | ||
| Q3 25 | 0.94× | 0.51× | ||
| Q2 25 | — | 0.73× | ||
| Q1 25 | — | 3.23× | ||
| Q4 24 | 0.90× | 18.25× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-25.7M | $22.0M |
| 自由现金流经营现金流 - 资本支出 | $-26.6M | — |
| 自由现金流率自由现金流/营收 | -37.0% | — |
| 资本支出强度资本支出/营收 | 1.3% | — |
| 现金转化率经营现金流/净利润 | -3.55× | 0.08× |
| 过去12个月自由现金流最近4个季度 | $-45.7M | — |
8季度趋势，按日历期对齐
经营现金流ABXRIGL
| Q4 25 | $-25.7M | $22.0M | ||
| Q3 25 | $-32.8M | $24.0M | ||
| Q2 25 | $76.1M | $30.5M | ||
| Q1 25 | $-61.6M | $-893.0K | ||
| Q4 24 | $-208.8M | $14.5M | ||
| Q3 24 | $-52.3M | $21.7M | ||
| Q2 24 | $-67.1M | $302.0K | ||
| Q1 24 | $2.5M | $-5.0M |
自由现金流ABXRIGL
| Q4 25 | $-26.6M | — | ||
| Q3 25 | $-32.9M | — | ||
| Q2 25 | $75.7M | — | ||
| Q1 25 | $-61.8M | — | ||
| Q4 24 | $-209.6M | — | ||
| Q3 24 | $-52.5M | — | ||
| Q2 24 | $-67.2M | — | ||
| Q1 24 | $2.4M | — |
自由现金流率ABXRIGL
| Q4 25 | -37.0% | — | ||
| Q3 25 | -52.3% | — | ||
| Q2 25 | 134.6% | — | ||
| Q1 25 | -140.0% | — | ||
| Q4 24 | -631.1% | — | ||
| Q3 24 | -186.6% | — | ||
| Q2 24 | -231.3% | — | ||
| Q1 24 | 10.9% | — |
资本支出强度ABXRIGL
| Q4 25 | 1.3% | — | ||
| Q3 25 | 0.3% | — | ||
| Q2 25 | 0.8% | — | ||
| Q1 25 | 0.5% | — | ||
| Q4 24 | 2.4% | — | ||
| Q3 24 | 0.9% | — | ||
| Q2 24 | 0.7% | — | ||
| Q1 24 | 0.8% | — |
现金转化率ABXRIGL
| Q4 25 | -3.55× | 0.08× | ||
| Q3 25 | -4.63× | 0.86× | ||
| Q2 25 | 4.33× | 0.51× | ||
| Q1 25 | -13.28× | -0.08× | ||
| Q4 24 | — | 1.01× | ||
| Q3 24 | — | 1.75× | ||
| Q2 24 | -87.09× | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ABX
| Life Solutions Segment | $63.0M | 88% |
| Asset Management Segment | $8.7M | 12% |
RIGL
暂无分部数据
